Perforation after a Percutaneous Biopsy from Metastatic Pancreatic Cancer

Shadin Ghabra^1, , Fatima Alharmoodi², Shahbazali Patil³ and Salem Alharthi⁴

¹Department of general surgery, Medstar Georgetown University Hospital, Washington D.C., USA

²Department of general surgery, Tawam Hospital, Al Ain, UAE

³Department of radiology, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, UAE

⁴Department of general surgery, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, UAE

Cite this paper

Shadin Ghabra, Fatima Alharmoodi, Shahbazali Patil and Salem Alharthi. Perforation after a Percutaneous Biopsy from Metastatic Pancreatic Cancer. American Journal of Medical Case Reports. 2022; 10(7):178-180. doi: 10.12691/AJMCR-10-7-4

Abstract

Metastatic adenocarcinoma of the pancreas has a poor prognosis. When distant metastasis occurs in the liver, image-guided percutaneous interventions are crucial for both diagnosis and treatment. In this case report, we describe a 67-year-old male with pancreatic adenocarcinoma and metastatic liver lesions. The lesions were biopsied leading to hemorrhage on post-procedure day seven.

Keywords

pancreatic cancer, liver metastasis, biopsy, Gelfoam, intervention radiology

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	National Cancer Institute: Cancer stat facts: Pancreatic cancer. https://seer.cancer.gov/statfacts/html/pancreas.html.
[2]	World Cancer Research Fund: Pancreatic cancer statistics. https://www.wcrf.org/dietandcancer/cancer-trends/pancreatic-cancer-statistics.
[3]	Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, Garrido-Laguna I, Lau MW, Johnson T, Krishnamurthi S, Moravek C, O'Reilly EM, Philip PA, Pant S, Shah MA, Sahai V, Uronis HE, Zaidi N, Laheru D. Metastatic Pancreatic Cancer: ASCO Guideline Update. J Clin Oncol. 2020 Aug 5:JCO2001364.
[4]	Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016 Jul 2; 388(10039): 73-85.
[5]	Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2018). Optimizing the outcomes of pancreatic cancer surgery. Nature Reviews Clinical Oncology.
[6]	Gillen, S., Schuster, T., Meyer Zum Buschenfelde, C., Friess, H. & Kleeff, J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLOS Med. 7, e1000267 (2010).
[7]	Kang, J., Hwang, I., Yoo, C. et al. Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis. Invest New Drugs 36, 732-741 (2018).
[8]	Asai A, Yokohama K, Ohama H, et al. Administration of Antithrombotic Treatment Was a Risk Factor for Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases.. Research Square; 2021.
[9]	Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, Karkhanis S, Lester W, Roslund N, West R, Wyatt JI, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020 Aug; 69(8): 1382-1403.
[10]	Gilmore IT, Burroughs A, Murray-Lyon IM, et al. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36: 437-41.
[11]	F. Durand, J.M. Regimbeau, J. Belghiti, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol, 35 (2001), pp. 254-258.
[12]	Tublin ME, Blair R, Martin J, Malik S, Ruppert K, Demetris A. Prospective study of the impact of liver biopsy core size on specimen adequacy and procedural complications. AJR 2018; 210: 183-188.
[13]	Sheth, R. A., Baerlocher, M. O., Connolly, B. L., Dariushnia, S. R., Shyn, P. B., Vatsky, S., Gupta, S. (2020). Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients. Journal of Vascular and Interventional Radiology, 31(11), 1840-1848.
[14]	Gupta, S., Wallace, M. J., Cardella, J. F., Kundu, S., Miller, D. L., & Rose, S. C. (2010). Quality Improvement Guidelines for Percutaneous Needle Biopsy. Journal of Vascular and Interventional Radiology, 21(7), 969-975.
[15]	Desai GS, Pande PM, Narkhede RA, Wagle PK. Multimodality Management of Ruptured Large Hepatocellular Carcinoma and Its Recurrence: Rupture at Presentation Should Not Rupture Hope of Long-Term Survival. Surg J (N Y). 2020; 6(2): e112-e117. Published 2020 Jun 16.
[16]	Dotan Y, Carlebach M, Zuckerman E, Maruf M, Schiff E. Delayed Bleeding after Percutaneous Liver Biopsy. Eur J Case Rep Intern Med. 2016; 3(2): 000359. Published 2016 Jan 18.
[17]	Uller W, Müller-Wille R, Grothues D, Schelling J, Zausig N, Loss M, Stroszczynski C, Wohlgemuth WA. Gelfoam for closure of large percutaneous transhepatic and transsplenic puncture tracts in pediatric patients. Rofo. 2014 Jul; 186(7): 693-7.
[18]	Tsang WK, Luk WH, Lo A. Ultrasound-guided plugged percutaneous biopsy of solid organs in patients with bleeding tendencies. Hong Kong Med J. 2014 Apr; 20(2): 107-12.
[19]	Méndez Gutiérrez TH, Dehesa Violante M, Rodríguez Jerkov J, de la Garza S, González Loya F. Biopsia hepática percutánea con taponamiento guiada por ultrasonido en pacientes con coagulación alterada. Informe preliminar [Ultrasound-guided percutaneous plugged biopsy of the liver in patients with coagulation disorders. Preliminary report]. Rev Gastroenterol Mex. 1990 Jan-Mar; 55(1): 13-5. Spanish. PMID: 2291061.